Director, Competitive Intelligence

Does it excite you to work with competitive intelligence in biotech, and do you have experience building and leading a best-in-class CI function? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.

Your new position

This role will lead the Competitive Intelligence function and set the strategy, operating model, and standards to inform decision-making across the portfolio. The position will harness external and internal data to generate clear, timely insights that shape planning, investor communications, and product development. The role will partner closely with research, development, medical affairs, commercial, and investor relations to anticipate market shifts and identify opportunities and threats. It offers high visibility and impact, with direct influence on strategic decisions across the portfolio and corporate narrative.

We offer exciting responsibilities:

• Drive the Competitive Intelligence strategy and act as the CI Center of Excellence across the organization
• Build and lead CI ways of working, tools, and processes to enable consistent, high-quality insights
• Monitor competitors, pipelines, market trends, regulations, partnerships, and emerging technologies; synthesize diverse data into clear insights
• Lead event intelligence at key congresses; track competitor activities and KOL sentiment; deliver rapid, actionable updates to leadership
• Collaborate across functions on category assessments, scenario planning, positioning, TPPs, go/no-go decisions, and business development support
• Maintain and grow external intelligence networks and sources to identify strategic threats and opportunities

Your profile

A strategic leader with a passion for the science–business interface who thrives in complex, fast-changing environments. Comfortable engaging in both technical and strategic discussions, translating complex datasets and trial designs into concise, decision-ready insights. Adept at influencing senior stakeholders through clear communication and evidence-based recommendations. Proficiency in English is required.

• Extensive experience in pharma/biotech/VC/analyst roles across science and business (e.g., new product planning, medical affairs, strategic planning, commercial, market analysis)
• Recent, hands-on competitive intelligence experience
• Strong quantitative and data analysis skills; able to translate preclinical/clinical data and study designs into strategic insights
• Expertise in obesity and/or cardiovascular–renal metabolism (scientific, medical, or commercial)
• Strategic agility and executive influence in matrixed settings
• Demonstrated ability to anticipate market shifts and shape strategy

Your new team

Based in the Investor Relations department, this role reports directly to the Vice President of Investor Relations and works cross-functionally with Commercial, Medical Affairs, Research, and other functions. The CI function will serve as a trusted partner to leadership, enabling evidence-based decisions and clear external communication across the organization.

Let's bond and be bold

We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.

Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.

Interested in bonding with us? Then please apply no later than
December 01, 2025
, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.

For further information, please contact
Vice President, Investor Relations
,
Adam Klyver Lange
,

We are committed to an inclusive recruitment process and welcome applications from all job applicants.

About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a team in the U.S. For more information about Zealand Pharma's business and activities, please visit